SEC Tracker
Get the app

Innospec IOSP

Innospec FY 2024: revenue $1.8B, down 5%; diluted EPS $1.42

Form
10-K
Filed
Period
Importance
Notable
Document
10-K

Key figures from this report

These are the numbers Innospec reported for the year ended Dec 31, 2024, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$1.8B−5% from $1.9B in FY 202310-K income statement, on EDGAR
  2. Diluted EPS$1.42−74% from $5.56 in FY 202310-K income statement, on EDGAR
  3. Cash and cash equivalents$289.2M+42% from $203.7M in FY 202310-K balance sheet, on EDGAR
  4. Cash from operations$184.5M−11% from $207.3M in FY 202310-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when Innospec files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2800 and related industry codes: the same peer list as the financial tables.

  1. Ingevity NGVT public float $1.6B, Jun 30, 2025
  2. Chemours CC public float $1.7B, Jun 30, 2025
  3. Huntsman HUN public float $1.7B, Jun 30, 2025
  4. Ecovyst ECVT public float $933M, Jun 30, 2025
  5. Perimeter Solutions PRM public float $1.9B, Jun 30, 2025